Clinical Trials Directory

Trials / Completed

CompletedNCT01212224

A Study of Minirin Melt in Patients With Nocturia

Retrospective Safety Study in 12 Months Treatment Nocturia With Minirin Melt in Clinical Practice in Czech Republic

Status
Completed
Phase
Study type
Observational
Enrollment
2,187 (actual)
Sponsor
Ferring Pharmaceuticals · Industry
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2013-03-01
Completion
2013-12-01
First posted
2010-09-30
Last updated
2014-01-06

Locations

81 sites across 1 country: Czechia

Source: ClinicalTrials.gov record NCT01212224. Inclusion in this directory is not an endorsement.